Radiometallated peptides targeting guanylate cyclase C and the urokinase-type plasminogen activator receptor

Author： Praharaj Snigdha   Overbey Douglas   Giblin Michael F  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.8, 2010-08, pp. : 1325-1337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

By Tecimer C.   Doering D.L.   Goldsmith L.J.   Meyer J.S.   Abdulhay G.   Wittliff J.L.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 48-55

Elsevier

Access to resources Recommend Favorite

Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells

By Mohan Pamarthi   Lakka Sajani   Mohanam Sanjeeva   Kin Yoshiaki   Sawaya Raymond   Kyritsis Anthanassios   Nicolson Garth   Rao Jasti  

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 617-621

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells

By Yanamandra Niranjan   Konduri Santhi   Mohanam Sanjeeva   Dinh Dzung   Olivero William   Gujrati Meena   Nicolson Garth   Obeyeseke Mandri   Rao Jasti  

Clinical and Experimental Metastasis, Vol. 18, Iss. 7, 2000-11 ,pp. : 611-615

Springer Publishing Company

Access to resources Recommend Favorite

Differential mRNA Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor Type-2 in Normal Human Endometria and Endometrial Carcinomas

By Foca C.   Moses E.K.   Quinn M.A.   Rice G.E.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 244-250

Elsevier

Access to resources Recommend Favorite